Trial Profile
A Study to Evaluate the Effect of Everolimus on Microvascular Remodeling and Coronary Flow Reserve (CFR) in Heart Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Ciclosporin (Primary) ; Everolimus (Primary) ; Mycophenolate mofetil
- Indications Heart transplant rejection
- Focus Pharmacodynamics
- Acronyms Anatomo-functional
- 30 Dec 2015 New trial record